Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells

被引:62
作者
Andersen, Thomas L. [1 ]
Soe, Kent [1 ]
Sondergaard, Teis E. [1 ]
Plesner, Torben [2 ]
Delaisse, Jean-Marie [1 ]
机构
[1] Univ So Denmark, IRS CSFU, Vejle Hosp, Dept Clin Cell Biol KCB, DK-7100 Veile, Denmark
[2] Univ So Denmark, IRS CSFU, Vejle Hosp, Dept Hematol, DK-7100 Veile, Denmark
关键词
myeloma; osteolysis; bone formation; bone resorption; cell fusion; HEPATOCYTE GROWTH-FACTOR; UROKINASE PLASMINOGEN-ACTIVATOR; HUMAN MULTIPLE-MYELOMA; UP-REGULATION; MATRIX METALLOPROTEINASES; IN-VIVO; DISEASE; DIFFERENTIATION; OSTEOBLASTS; RESORPTION;
D O I
10.1111/j.1365-2141.2009.07980.x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Osteolytic lesions are a hallmark of multiple myeloma. They are due to the hyperactivity of bone resorbing osteoclasts and hypoactivity of bone forming osteoblasts, in response to neighbouring myeloma cells. This study identified a structure that deeply affects this response, because of its impact on the physical organisation of the myeloma cell microenvironment. The proximity between myeloma cells and osteoclasts or osteoblasts was shown to be conditioned by the recently discovered layer of flat cells that separates the osteoclasts and osteoblasts from the bone marrow, by forming a canopy over bone remodelling compartment (BRC). These canopies are frequently disrupted in myeloma, and this disruption correlates with increased proximity and density of myeloma cells. In vitro evidence indicates that this disruption may be due to direct contact between myeloma and BRC canopy cells. Importantly, this disruption and increased proximity and density of myeloma cells coincides with key myeloma-induced bone events, such as osteolytic lesions, impaired bone formation despite increased bone resorption, and fusion of myeloma cells with osteoclasts thereby forming myeloma-osteoclast hybrid cells. These findings strongly support a critical role of BRC canopies in myeloma-induced bone disease. BRC canopies could therefore be considered as a new therapeutic target.
引用
收藏
页码:551 / 561
页数:11
相关论文
共 40 条
[1]
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion [J].
Abe, M ;
Hiura, K ;
Wilde, J ;
Shioyasono, A ;
Moriyama, K ;
Hashimoto, T ;
Kido, S ;
Oshima, T ;
Shibata, H ;
Ozaki, S ;
Inoue, D ;
Matsumoto, T .
BLOOD, 2004, 104 (08) :2484-2491
[2]
Chemokines in multiple myeloma [J].
Aggarwal, Rohit ;
Ghobrial, Irene A. ;
Roodman, G. David .
EXPERIMENTAL HEMATOLOGY, 2006, 34 (10) :1289-1295
[3]
Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone:: a new type of cancer-host partnership? [J].
Andersen, T. L. ;
Boissy, P. ;
Sondergaard, T. E. ;
Kupisiewicz, K. ;
Plesner, T. ;
Rasmussen, T. ;
Haaber, J. ;
Kolvraa, S. ;
Delaisse, J-M .
JOURNAL OF PATHOLOGY, 2007, 211 (01) :10-17
[4]
A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone [J].
Andersen, Thomas Levin ;
Sondergaard, Teis Esben ;
Skorzynska, Katarzyna Ewa ;
Dagnaes-Hansen, Frederik ;
Plesner, Trine Lindhardt ;
Hauge, Ellen Margrethe ;
Plesner, Torben ;
Delaisse, Jean-Marie .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (01) :239-247
[5]
MECHANISMS OF BONE DESTRUCTION IN MULTIPLE-MYELOMA - THE IMPORTANCE OF AN UNBALANCED PROCESS IN DETERMINING THE SEVERITY OF LYTIC BONE-DISEASE [J].
BATAILLE, R ;
CHAPPARD, D ;
MARCELLI, C ;
DESSAUW, P ;
SANY, J ;
BALDET, P ;
ALEXANDRE, C .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) :1909-1914
[6]
RECRUITMENT OF NEW OSTEOBLASTS AND OSTEOCLASTS IS THE EARLIEST CRITICAL EVENT IN THE PATHOGENESIS OF HUMAN MULTIPLE-MYELOMA [J].
BATAILLE, R ;
CHAPPARD, D ;
MARCELLI, C ;
DESSAUW, P ;
BALDET, P ;
SANY, J ;
ALEXANDRE, C .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :62-66
[7]
EXCESSIVE BONE-RESORPTION IN HUMAN PLASMACYTOMAS - DIRECT INDUCTION BY TUMOR-CELLS IN-VIVO [J].
BATAILLE, R ;
CHAPPARD, D ;
BASLE, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (03) :721-724
[8]
Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoclast differentiation [J].
Boissy, P ;
Andersen, TL ;
Abdallah, BM ;
Kassem, M ;
Plesner, T ;
Delaissé, JM .
CANCER RESEARCH, 2005, 65 (21) :9943-9952
[9]
TRANSFORMING GROWTH-FACTOR-BETA AND REMODELING OF BONE [J].
CENTRELLA, M ;
MCCARTHY, TL ;
CANALIS, E .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1991, 73A (09) :1418-1428
[10]
Bone marrow and bone: a functional unit [J].
Compston, JE .
JOURNAL OF ENDOCRINOLOGY, 2002, 173 (03) :387-394